Although the global vaccine output of the Global Covid-19 is increasing rapidly, the lack of raw materials and equipment can cause the production process to meet obstacles: 00: 00/5: 09Nain in March, an important European Union (EU) revealed Vaccine NOVAVAX manufacturer COVAVAX COVING-19 for Europe for Europe because this enterprise lacks materials, according to Reuters. Adar Poonawalla, Executive Director Indian Seremar Institute (SII), Participants in Vaccine Novavax, said this organization lacks special nylon bags and filters used in vaccine culture. According to him, the cause of this deficiency is the ban on the export of raw materials to produce US vaccines. "The production process of Novavax vaccine needs these materials from the United States," said Poonawalla. "The sharing of raw materials is an obstacle
. No one said this issue earlier.When the world boosted the production of vaccines, ensuring the supply of essential raw materials is the core factor to help mankind the immune immunity and escape the pandemic . Encreare with production of raw materials that record the most deficiency is a large nylon bag used in vaccine culture in a biological reactor
Nylon bags with this 2,000-liter capacity need to be used to produce all 4 types of vaccines in the present market. Stan Erck, CEO of Novavax, calling this shortage is "threat to source Global vaccine supply ". A Vaccine Novavax manufacturing facility in Vigo, Spain. Photo: New York Times. The vaccine manufacturing industry also has a large demand for dedicated filters and plastic pipes. These are only disposable materials once. Similar to nylon bags, they are used during the production of all 4 types of vaccines. Not only lack of equipment, some vaccine manufacturers lack raw materials such as lipid nanoparticles. These are micro-molecules used in MARN vaccines such as Vaccine of Moderna or Pfizer / Biontech. Nano lipid is responsible for wrapping vaccine elements to easily put into the body
Before Covid-19, Nano Lipid only was tested on a very small scale, thus expanding production is not easy. Materials, engineers, experienced workers are also Important factor in vaccine production. Some enterprises recorded a shortage of skilled workers for some special positions. According to Mr. Matthew Downham, leadership production department at the Creative Innovation Alliance is ready for epidemics (CEPI), businesses Industry not only has difficulty moving workers between factories. They face greater challenges in coordinating workers to other companies with a vaccine production contract. To address this situation, the pharmaceutical industry recommends that governments allow workers to move between Countries are easier. Besides "hard" barriers, "soft" barriers are also significant obstacles to the process of increasing global vaccine output. Currently, most countries around the world, including the United States, supporting the lifting of intellectual property rights with vaccines. This is a proposal of South Africa and India from 2020. According to Ms. Navya Dasari, a member of the student alliance organization for essential drugs (UAEM), lifting intellectual property rights "can help Increasing the vaccine output, minimizing barriers in the supply chain and helping new manufacturers to enter the market can export vaccines to countries with demand without having to worry about law. " Increasing vaccine supply is considered the key to humanity to overcome pandemic. Photo: US News.TUY, European Union and vaccine manufacturers object to this measure. According to them, new companies cannot instantly produce vaccines, although intellectual property rights are abolished. Dasari acknowledged the pharmaceutical industry to promote technology transfer, with the restoration Wisdom with vaccine. "Although intellectual property rights are lifted, we cannot guarantee that large pharmaceutical companies will share their business secrets," she said to Zing.Charging barriers to the production target Applying 11 billion doses of vaccines worldwide until the end of 2021. This figure is 3 times the annual vaccine output. However, this goal can only be achieved if barriers both "hard" and "soft" are removed. The world bank (WB) is concerned that barriers can cause humanity that cannot be achieved immunity Community in March 3/2022 as earlier forecast of this agency. Dowham Doctor said "Tons of jobs are being implemented" to reduce pressure on essential materials, helping them transport to Places with the fastest demand can. A global fast response team on this issue was organized. Besides, the Global Vaccine Sharing Mechanism Covax established the Purchase Platform Covax Marketplace. This platform is expected to help providers and manufacturers of trading vaccines. In the first stage, Covax Marketplace . Dịch vụ:
Thiết kế website,
quảng cáo google,
đăng ký website bộ công thương uy tín
